A Phase III Clinical Trial of PROCRIT (Epoetin Alfa) Versus Placebo in Women Undergoing Adjuvant Chemotherapy for Stage I, II or III Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Anemia|Breast Neoplasms|Hemoglobins|Quality of Life|Chemotherapy, Adjuvant
Interventions: DRUG: epoetin alfa
Sponsor: Ortho Biotech Products, L.P.